技术的整合为帕金森病患者的家庭视觉认知培训干预:未来是数字化的吗?
Julia Das1,2, Gill Barry1, Richard Walker2
1Department of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle upon Tyne, United Kingdom.
PloS one
|June 15, 2023
概括
技术视觉认知培训 (TVT) 为帕金森病康复提供了一种新的方法. 患者的经验强调,TVT的成功实施取决于感知价值,易用性和专业支持.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 人与计算机的交互
背景情况:
- 移动应用程序和技术正在越来越多地取代视觉认知训练的传统笔纸方法.
- 技术视觉认知训练 (TVT) 干预措施在治疗帕金森病等长期神经疾病中的视觉认知功能障碍方面表现有前途.
- 患者的观点对于了解新型TVT在治疗慢性神经疾病中的接收至关重要.
研究的目的:
- 探索患有帕金森病的个人的经验,利用技术进行家庭视觉认知训练.
- 通过技术视觉认知培训 (TVT) 进行患者体验,与传统康复方法进行比较.
- 评估将新型TVT纳入帕金森病患者的家庭康复治疗的潜力.
主要方法:
- 对八名帕金森病患者进行了定性采访,他们参与了一项试点随机交叉试验.
- 这项研究调查了患者对TVT和标准护理干预的经验.
- 规范化过程理论 (NPT) 被整合到分析中,以检查TVT的嵌入性.
主要成果:
- 主题分析确定了影响TVT实施的三个关键主题:技术的感知价值,易用性和支持机制.
- 规范化过程理论 (NPT) 分析表明,成功采用技术取决于用户体验,个体疾病特征和专业参与.
- 由于帕金森病的进展性和波动性,患者的经验揭示了参与基于技术的干预的挑战.
结论:
- 对帕金森病实施基于技术的干预措施需要仔细考虑疾病的渐进和波动性.
- 患者和临床医生之间的合作至关重要,以确保技术与个人能力,偏好和治疗需求保持一致.
- 进一步的研究应该专注于优化TVT的整合到帕金森病的个性化康复计划中.
更多相关视频
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.2K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.9K
相关概念视频
Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
Parkinson's Disease: Overview
611
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
611
